Functional effects of expression of wolframin-antisense transcripts in BRIN-BD11 β-cells

被引:7
作者
McBain, SC
Morgan, NG
机构
[1] Peninsula Med Sch, Inst Biomed & Clin Sci, Plymouth PL6 8BX, Devon, England
[2] Univ Keele, Sch Life Sci, Keele ST5 5BG, Staffs, England
基金
英国生物技术与生命科学研究理事会;
关键词
Islets of Langerhans; Wolfram syndrome; pancreatic beta-cell; proliferation; insulin secretion; DIDMOAD;
D O I
10.1016/S0006-291X(03)01243-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wolfram syndrome is a rare condition in which the pancreatic beta-cells of patients are selectively deleted during the early years of life by a non-autoimmune-mediated mechanism. The condition is associated with mutations in the gene encoding wolframin, suggesting that this protein exerts a critical, but currently unknown, function in beta-cells. We have used an antisense strategy to modulate the expression of wolframin in insulin-secreting BRIN-BD11 cells to study its function. Stably transfected clones were established expressing full-length human wolframin antisense transcripts. These cells exhibited a dramatic reduction in cell proliferation rate and changes in morphology, although insulin secretion was not modified. The results imply that wolframin expression is required to sustain normal rates of beta-cell proliferation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:684 / 688
页数:5
相关论文
共 18 条
[11]   GENETICALLY PROGRAMMED SELECTIVE ISLET BETA-CELL LOSS IN DIABETIC SUBJECTS WITH WOLFRAMS SYNDROME [J].
KARASIK, A ;
OHARA, C ;
SRIKANTA, S ;
SWIFT, M ;
SOELDNER, JS ;
KAHN, CR ;
HERSKOWITZ, RD .
DIABETES CARE, 1989, 12 (02) :135-138
[12]   WFS1/Wolframin mutations, Wolfram syndrome, and associated diseases [J].
Khanim, F ;
Kirk, J ;
Latif, F ;
Barrett, TG .
HUMAN MUTATION, 2001, 17 (05) :357-367
[13]   Expression of alpha(2)- and beta-adrenoceptor subtypes in human islets of Langerhans [J].
Lacey, RJ ;
Chan, SLF ;
Cable, HC ;
James, RFL ;
Perrett, CW ;
Scarpello, JHB ;
Morgan, NG .
JOURNAL OF ENDOCRINOLOGY, 1996, 148 (03) :531-543
[14]   Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion [J].
McClenaghan, NH ;
Barnett, CR ;
AhSing, E ;
AbdelWahab, YH ;
OHarte, FPM ;
Yoon, TW ;
SwanstonFlatt, SK ;
Flatt, PR .
DIABETES, 1996, 45 (08) :1132-1140
[15]   Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein [J].
Strom, TM ;
Hörtnagel, K ;
Hofmann, S ;
Gekeler, F ;
Scharfe, C ;
Rabl, W ;
Gerbitz, KD ;
Meitinger, T .
HUMAN MOLECULAR GENETICS, 1998, 7 (13) :2021-2028
[16]   WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain [J].
Takeda, K ;
Inoue, H ;
Tanizawa, Y ;
Matsuzaki, Y ;
Oba, J ;
Watanabe, Y ;
Shinoda, K ;
Oka, Y .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :477-484
[17]  
Wolfram D.J., 1938, P MAYO CLIN, V9, P715
[18]   Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats [J].
Xu, G ;
Stoffers, DA ;
Habener, JF ;
Bonner-Weir, S .
DIABETES, 1999, 48 (12) :2270-2276